Project Scope

To understand the assess the feasibility of an oncology portfolio by conducting extensive secondary research and primary research with payers and oncologists to identify the best launch and pricing strategies for the MEA region

Challenge

Our client has a breadth of innovative and generic oncology drugs and was looking to understand how to leverage their portfolio and get greater uptake through a portfolio contracting approach

Solution

• Extensive secondary research into core markets and operating mechanisms
• Primary research consisting of qualitative discussions with payers and oncologists
• Identification of strategies based on the analysis carried out

Results

• Facilitated client understanding of key innovative contracts in oncology through in-depth strategic analysis of Egypt, Saudi Arabia, Morocco and UAE markets
• Prioritization of the products to be placed in the oncology portfolio deal